Selective Incorporation of Hetes into Epidermal Phospholipids
Part of the
GWUMC Department of Biochemistry Annual Spring Symposia
book series (GWUN)
The skin has an active lipid metabolism and is capable of producing a variety of eicosanoids (Ruzicka and Printz, 1984). Recently, there has been particular attention directed toward the existence of epidermal lipoxygenase products and their possible role in cutaneous inflammation (Voorhees, 1983; Camp and Cunningham, 1988). This interest began with the discovery that the lesions of certain chronic inflammatory skin disorders (e.g. psoriasis and atopic dermatitis) are associated with an imbalance of lipoxygenase products, specifically elevated levels of pro-inflammatory leukotriene B4 (LTB4), a 5-lipoxygenase product of leukocytes (Grabbe et al., 1984; Brain et al., 1984; Ruzicka et al., 1986). Interestingly, the major lipoxygenase product of keratinocytes (the predominant epidermal cell-type) is the 15-lipoxygenase product 15-hydroxyeicosatetraenoic acid (15-HETE) (Burrall et al., 1985; Nugteren and Kivits, 1987), an inhibitor of 5--lipoxygenase activity in vitro (Vanderhoek et al., 1982). The potential of epidermally-derived 15-HETE to attenuate 5-lipoxygenase activity has led to speculation that there may be a local deficit of 15-HETE in lesional tissues which may in turn result in a decreased ability to limit the generation of 5-lipoxygenase products by infiltrating leukocytes. In support of this hypothesis, intralesional injections of 15-HETE have been used to clear psoriatic lesions (Fogh et al., 1988). Furthermore, certain dietary oils that result in elevated in vivo levels of epidermal 15-lipoxygenasejproducts (Miller et al., 1990; Miller et al., 1991) have been shown to be clinically effective in the treatment of psoriasis and other chronic inflammatory skin disorders (Ziboh et al., 1986; Maurice et al., 1987; Wright and Burton, 1982).
KeywordsHydroxy Fatty Acid Phospholipid Class Intralesional Injection Lipoxygenase Product Inositol Phospholipid
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Brain S., Camp R., Dowd P., Kobza Black A., and Greaves M., 1984, The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis, J. Invest. Dermatol.
83: 70–73.PubMedCrossRefGoogle Scholar
Brezinski M.E. and Serhan C.N., 1990, Selective incorporation of (15S)hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: Agonist-induced deacylation and transformation of stored hydroxyeicosanoids, Proc. Natl. Acad. Sci.
87: 6248–6252.PubMedCrossRefGoogle Scholar
Burrall B.A., Wintroub B.U., and Goetzl E.J., 1985, Selective expression of 15-lipoxygenase activity by cultured human keratinocytes, Biochem. Biophys. Res. Commun.
133: 208–213.PubMedCrossRefGoogle Scholar
Burrall B.A., Cheung M., Chill A., and Goetzl E.J., 1988, Enzymatic properties of the 15-lipoxygenase of human cultured keratinocytes, J. Invest. Dermatol.
91: 294–297.PubMedCrossRefGoogle Scholar
Camp R.D.R. and Cunningham F.M., 1988, The role of eicosanoids in inflammatory disorders of the skin, in Eicosanoids in Inflammatory Conditions of the Lung
, and Joints
, Church M. and Robinson C., eds., MTP Press Ltd., Boston, pp 112–128.Google Scholar
Croset M. and Lagarde M., 1983, Stereospecific inhibition of PGH2- induced platelet aggregation by lipoxygenase products of icosanoic acids, Biochem. Biophys. Res. Commun.
112: 878–883.PubMedCrossRefGoogle Scholar
Fogh K., Sogaard H., Herlin T., and Kragballe K., 1988, Improvement of psoriasis vulgaris after intralesional injections of 15-hydroxyeicosatetraenoic acid (15-HETE), J. Am. Acad. Dermatol.
18: 279–285.PubMedCrossRefGoogle Scholar
Grabbe J., Czarnetzki B.M., Rosenbach T., and Mardin M., 1984, Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin, J. Invest. Dermatol.
82: 477–479.PubMedCrossRefGoogle Scholar
Green F.A., 1989, Generation and metabolism of lipoxygenase products in normal and membrane-damaged cultured human keratinocytes, J. Invest. Dermatol.
93: 486–491.PubMedCrossRefGoogle Scholar
Holub B.J. and Skeaff C.M., 1987, Nutritional regulation of cellular phosphatidylinositol, Methods Enzymol
. 141: 234–244.PubMedCrossRefGoogle Scholar
Legrand A.B., Lawson J.A., Meyrick B.O., Blair I.A., and Oates J.A., 1991, Substitution of 15-hydroxyeicosatetraenoic acid in the phosphoinositide signaling pathway, J. Biol. Chem.
266: 7570–7577.PubMedGoogle Scholar
Maurice P.D.L., Allen B.R., Barkley A.S.J., Cockbill S.R., Stammers J., and Bather P.C., 1987, The effects of dietary supplementation with fish oil in patients with psoriasis, Br. J. Dermatol.
117: 599–606.PubMedCrossRefGoogle Scholar
Miller C.C., Ziboh V.A., Wong T., and Fletcher M.P., 1990, Dietary supplementation with oils rich in n-3 and n-6 fatty acids influences in vivo levels of epidermal lipoxygenase products in guinea pigs, J. Nutr.
120: 36–44.PubMedGoogle Scholar
Miller C.C., Tang W., Ziboh V.A., and Fletcher M.P., 1991, Dietary supplementation with ethyl ester concentrates of fish oil (n-3) and borage oil (n-6) polyunsaturated fatty acids induces epidermal generation of local putative antiinflammatory metabolites, J. Invest. Dermatol.
96: 98–103.PubMedCrossRefGoogle Scholar
Nugteren D.H. and Kivits G.A.A., 1987, Conversion of linoleic acid and arachidonic acid by skin epidermal lipoxygenases, Biochim. Biophys. Acta.
921: 135–141.PubMedCrossRefGoogle Scholar
Ruzicka T.P. and Printz M.P., 1984, Arachidonic acid metabolism in skin: a review, Rev. Physiol. Biochem. Pharmacol.
100: 121–160.PubMedGoogle Scholar
Ruzicka T., Sirmet T., Peskar B.A., and Ring J., 1986, Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis, J. Invest. Dermatol.
86: 105–108.PubMedCrossRefGoogle Scholar
Spector A.A., Gordon J.A., and Moore S.A., 1988, Hydroxyeicosatetraenoic acids (HETEs), Prog. Lipid. Res.
27: 271–323.PubMedCrossRefGoogle Scholar
Vanderhoek J.Y., Bryant R.W., and Bailey, J.M., 1982, Regulation of leukocyte and plateletGoogle Scholar
lipoxygenases by hydroxy-eicosanoids, Biochem. Pharmacol.
31:3463–3467. Voorhees J.J., 1983, Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses, Arch. Dermatol.
Wright S. and Burton J.L., 1982, Oral evening-primrose-seed oil improves atopic eczema, Lancet II,1120–1122.CrossRefGoogle Scholar
Ziboh V.A., Cohen K.A., Ellis C.N., Miller C., Hamilton T.A., Kragballe K., Hydrick C.R., and Voorhees J.J., 1986, Effects of dietary supplementation of fish oil on neutrophil and epidermal fatty acids. Modulation of clinical course of psoriatic subjects, Arch. Dermatol.
122: 1277–1282.PubMedCrossRefGoogle Scholar
© Springer Science+Business Media New York 1991